Sirnaomics Ltd. (HKG:2257)
5.29
-0.63 (-10.64%)
Jun 1, 2026, 3:58 PM HKT
Sirnaomics Market Cap
Sirnaomics has a market cap or net worth of 576.07 million as of June 1, 2026. Its market cap has increased by 80.42% in one year.
Market Cap
576.07M
Enterprise Value
429.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.29
Market Cap Chart
Since December 30, 2021, Sirnaomics's market cap has decreased from 6.86B to 576.07M, a decrease of -91.60%. That is a compound annual growth rate of -42.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 644.68M | -21.00% |
| Dec 31, 2025 | 816.08M | 126.04% |
| Dec 31, 2024 | 361.03M | -88.38% |
| Dec 29, 2023 | 3.11B | -38.75% |
| Dec 30, 2022 | 5.07B | -36.82% |
| Dec 31, 2021 | 8.03B | 17.07% |
| Dec 30, 2021 | 6.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.21B |
| Kintor Pharmaceutical | 1.09B |
| Sunho Biologics | 970.43M |
| 3D Medicines | 836.76M |
| Wuhan YZY Biopharma | 833.55M |
| Brii Biosciences | 830.08M |
| JW (Cayman) Therapeutics Co. | 754.97M |
| Shanghai Bio-heart Biological Technology | 735.12M |